title: [Electroconvulsion therapy for neuroleptic malignant syndrome].
abstract: A 64-year-old man, diagnosed with recurrent depression, developed a neuroleptic malignant syndrome (nms) during treatment with olanzapine and mirtazapine. Psychotropic drugs were discontinued. Supportive therapy in an intensive care setting was initiated and electroconvulsive therapy (ect) was administered, after which the patient recovered. This case report discusses the place of ect in the treatment of nms.
authors.forename: S
authors.initials: S
authors.lastname: Buggenhout
authors.forename: J
authors.initials: J
authors.lastname: Vandenberghe
authors.forename: P
authors.initials: P
authors.lastname: Sienaert
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D004565:Electroconvulsive Therapy / Q000379:methods*; D006801:Humans; D008297:Male; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D000078785:Mirtazapine; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology* / Q000628:therapy*; D000077152:Olanzapine
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D008803:Mianserin; D000078785:Mirtazapine; D000077152:Olanzapine